Pepcid ac and Keppra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pepcid ac (famotidine) and Keppra (levetiracetam). Common drug interactions include foetal exposure during pregnancy among females and foetal exposure during pregnancy among males.

The phase IV clinical study analyzes what interactions people have when they take Pepcid ac and Keppra. It is created by eHealthMe based on reports of 49 people who take the same drugs from the FDA, and is updated regularly.

What is Pepcid ac?

Pepcid ac has active ingredients of famotidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 9,573 Pepcid ac users. Check the latest studies of Pepcid ac.

What is Keppra?

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 73,504 Keppra users. Check the latest studies of Keppra.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

49 people who take Pepcid ac and Keppra together, and have interactions are studied.

Pepcid ac and Keppra drug interactions.

What are the common drug interactions of Pepcid Ac and Keppra, by gender? *:

female:

  1. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  2. Premature baby
  3. Abnormal palmar/plantar creases (normal groove across the palm of the hand)
  4. Dysmorphism (difference of body structure that is suggestive of a congenital disorder)
  5. Somnolence (a state of near-sleep, a strong desire for sleep)
  6. Chronic kidney disease
  7. Nausea (feeling of having an urge to vomit)
  8. Death
  9. Drug ineffective
  10. Headache (pain in head)

male:

  1. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  2. Premature baby
  3. Death
  4. Fall
  5. Pruritus (severe itching of the skin)
  6. Chronic kidney disease
  7. Coma (state of unconsciousness lasting more than six hours)
  8. Constipation
  9. Dizziness
  10. Glioblastoma (most common and most aggressive malignant primary brain tumour in humans)

What are the common drug interactions of Pepcid Ac and Keppra, by age (0-1 to 60+)? *:

0-1:

  1. Flushing (the warm, red condition of human skin)

2-9:

  1. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  2. Premature baby

10-19:

n/a

20-29:

  1. Death
  2. Coma (state of unconsciousness lasting more than six hours)
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  4. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  5. Overdose
  6. Pulmonary embolism (blockage of the main artery of the lung)

30-39:

  1. Chronic kidney disease
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  3. Fall
  4. Glioblastoma (most common and most aggressive malignant primary brain tumour in humans)
  5. Headache (pain in head)
  6. Nausea (feeling of having an urge to vomit)
  7. Renal failure (kidney dysfunction)
  8. Subarachnoid haemorrhage (blood leaks into the space between two membranes that surround the brain)
  9. Traumatic intracranial haemorrhage (a bleeding in brain due to trauma)

40-49:

  1. Nausea (feeling of having an urge to vomit)
  2. Influenza
  3. Wheezing (a high-pitched whistling sound made while you breath)
  4. Death
  5. Headache (pain in head)
  6. Hiccups (an involuntary spasm of the diaphragm and respiratory organs, with a sudden closure of the glottis and a sound like a cough)

50-59:

  1. Abnormal palmar/plantar creases (normal groove across the palm of the hand)
  2. Dysmorphism (difference of body structure that is suggestive of a congenital disorder)
  3. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  4. Hypotonia (low muscle tone)
  5. Premature baby
  6. Abdominal pain
  7. Decreased appetite
  8. Hyperchlorhydria (gastric acid levels are higher in stomach)
  9. Pleural effusion (water on the lungs)
  10. Chronic kidney disease

60+:

  1. Chronic kidney disease
  2. Lipase increased
  3. Pruritus (severe itching of the skin)
  4. Rash macular (small, flat red spots)
  5. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  6. Urticaria (rash of round, red welts on the skin that itch intensely)
  7. Renal failure (kidney dysfunction)
  8. Death
  9. Dizziness
  10. Fall

What are the existing conditions these people have? *

  1. Stress And Anxiety: 14 people, 28.57%
  2. Headache (pain in head): 13 people, 26.53%
  3. Indigestion: 11 people, 22.45%
  4. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 10 people, 20.41%
  5. Birth Control: 10 people, 20.41%
  6. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 6 people, 12.24%
  7. Immunodeficiency Common Variable: 4 people, 8.16%
  8. High Blood Pressure: 4 people, 8.16%
  9. Pain: 3 people, 6.12%
  10. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 6.12%

* Approximation only. Some reports may have incomplete information.

Do you take Pepcid ac and Keppra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pepcid ac and Keppra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pepcid ac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Keppra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pepcid ac and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Keppra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on famotidine and levetiracetam (the active ingredients of Pepcid ac and Keppra, respectively), and Pepcid ac and Keppra (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: